# Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas

> **NCT04937244** · PHASE4 · UNKNOWN · sponsor: **Northwell Health** · enrollment: 10 (estimated)

## Conditions studied

- Malignant Glioma of Brain

## Interventions

- **DIAGNOSTIC_TEST:** 5ALA exoscopic fluorescence filter

## Key facts

- **NCT ID:** NCT04937244
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-13
- **Primary completion:** 2022-05-11
- **Final completion:** 2022-05-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937244, "Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*